The Journal of Immunology · 1958 · 16 citations · 0 references
Life SciencesBiochemistryMicrobiologyBacteriologyClinical BiochemistryMedical MicrobiologyAntibacterial AgentsMedical BacteriologyAntibacterial ImmunityBacillus SubtilisBactericidal AgentsBacteriostatic ActivityLytic Enzymes
Summary The serum levels of bactericidin activity against Bacillus subtilis were studied in several disease states in humans. Myocardial infarction produced a marked rise about the fifth postsymptom day. Patients with lobar pneumonia demonstrated maximum titers during the acute phase of their disease, usually during the first hospital day. Metastatic malignancies also resulted in elevated serum levels. Several other conditions produced little effect on serum bactericidin levels.